CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-14 | Glenn Gregory M President, R&D | Grant or award · Restricted Stock Units | +9,300 | 9,300 | ||
| 2020-12-14 | Erck Stanley C President and CEO | Grant or award · Stock Option (Right to Buy) | +41,700 | 41,700 | ||
| 2020-12-14 | Erck Stanley C President and CEO | Grant or award · Restricted Stock Units | +20,900 | 20,900 | ||
| 2020-12-07 | MCGLYNN MARGARET G Director | Grant or award · Stock Option (Right to buy) | +7,700 | 7,700 | ||
| 2020-12-05 | YOUNG JAMES F Director | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2020-11-16 | Erck Stanley C President and CEO | Exercise or conversion | +42,499 | $39.80 | $1.7M | 62,993 |
| 2020-11-16 | Erck Stanley C President and CEO | Exercise or conversion | +9,818 | $25.60 | $251K | 72,811 |
| 2020-11-16 | Erck Stanley C President and CEO | Sale | −5,766 | $87.20 | $503K | 67,045 |
| 2020-11-16 | Erck Stanley C President and CEO | Sale | −8,306 | $88.36 | $734K | 58,739 |
| 2020-11-16 | Erck Stanley C President and CEO | Sale | −11,234 | $89.26 | $1.0M | 47,505 |
| 2020-11-16 | Erck Stanley C President and CEO | Sale | −4,598 | $90.61 | $417K | 42,907 |
| 2020-11-16 | Erck Stanley C President and CEO | Sale | −17,503 | $92.97 | $1.6M | 25,404 |
| 2020-11-16 | Erck Stanley C President and CEO | Sale | −4,909 | $93.56 | $459K | 20,495 |
| 2020-11-16 | Erck Stanley C President and CEO | Exercise or conversion · Stock Option (Right to buy) | −42,499 | 0 | ||
| 2020-11-16 | Erck Stanley C President and CEO | Exercise or conversion · Stock Option (Right to buy) | −9,818 | 35,182 | ||
| 2020-11-16 | COVINO GREGORY F EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +7,300 | 7,300 | ||
| 2020-11-16 | COVINO GREGORY F EVP, Chief Financial Officer | Grant or award · Stock Option (Right to buy) | +8,200 | 8,200 | ||
| 2020-10-31 | Alton Gregg H Director | Grant or award · Stock Option (Right to buy) | +7,700 | 7,700 | ||
| 2020-10-01 | Erck Stanley C President and CEO | Sale | −2 | $108.57 | $217 | 20,494 |
| 2020-09-30 | Trizzino John EVP, CBO and CFO | Sale | −79 | $107.60 | $9K | 7,258 |
Page 75 of 87 · 1,734 trades